Cargando…
Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models
BACKGROUND: Diffuse-type gastric cancer (DGC) exhibits rapid disease progression and poor patient prognosis. We have previously established an E-cadherin/p53 double conditional knockout (DCKO) mouse line as the first genetically engineered one, which morphologically and molecularly recapitulates hum...
Autores principales: | Shimada, Shu, Akiyama, Yoshimitsu, Mogushi, Kaoru, Ishigami-Yuasa, Mari, Kagechika, Hiroyuki, Nagasaki, Hiromi, Fukamachi, Hiroshi, Yuasa, Yasuhito, Tanaka, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931092/ https://www.ncbi.nlm.nih.gov/pubmed/29527007 http://dx.doi.org/10.1038/s41416-018-0008-y |
Ejemplares similares
-
Chemical Screening of Nuclear Receptor Modulators
por: Ishigami-Yuasa, Mari, et al.
Publicado: (2020) -
Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model
por: Rotkrua, P, et al.
Publicado: (2013) -
DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells
por: Sakamoto, Ayuna, et al.
Publicado: (2015) -
Frequent Microsatellite Instabilities and Analyses of the Related Genes in Familial Gastric Cancers
por: Akiyama, Yoshimitsu, et al.
Publicado: (1996) -
Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer
por: Nishikawaji, Taketo, et al.
Publicado: (2016)